Search Results - "Taniai, Eriko"

Refine Results
  1. 1

    Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats by Taniai, Eriko, Yafune, Atsunori, Nakajima, Masahiro, Hayashi, Shim-Mo, Nakane, Fumiyuki, Itahashi, Megu, Shibutani, Makoto

    Published in Toxicology letters (03-01-2014)
    “…•Ochratoxin A induces karyomegaly in renal tubular cells without relation to induction of oxidative stress in rats.•Ochratoxin A causes cell cycle aberrations…”
    Get full text
    Journal Article
  2. 2

    Aberrant activation of M phase proteins by cell proliferation-evoking carcinogens after 28-day administration in rats by Yafune, Atsunori, Taniai, Eriko, Morita, Reiko, Hayashi, Hitomi, Suzuki, Kazuhiko, Mitsumori, Kunitoshi, Shibutani, Makoto

    Published in Toxicology letters (07-06-2013)
    “…•This study aimed to identify early prediction markers of carcinogens in rats.•Cellular distribution of cell cycle proteins was analyzed after 28-day…”
    Get full text
    Journal Article
  3. 3

    Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action by Hayashi, Hitomi, Shimamoto, Keisuke, Taniai, Eriko, Ishii, Yuji, Morita, Reiko, Suzuki, Kazuhiko, Shibutani, Makoto, Mitsumori, Kunitoshi

    Published in Journal of toxicological sciences (2012)
    “…Omeprazole (OPZ), a proton pump inhibitor, is a cytochrome P450 (CYP) 1A1/2 inducer. Some CYP1A inducers are known to have liver tumor promoting effects in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats by Kemmochi, Yusuke, Ohta, Takeshi, Motohashi, Yu, Kaneshige, Akihiro, Katsumi, Sohei, Kakimoto, Kochi, Yasui, Yuzo, Anagawa-Nakamura, Akiko, Toyoda, Kaoru, Taniai-Riya, Eriko, Takahashi, Akemi, Shoda, Toshiyuki, Yamada, Takahisa

    Published in Journal of Toxicologic Pathology (01-01-2018)
    “…Sarcopenia is the age-related decrease of muscle mass and function. Diabetes and obesity are known to be risk factors that exacerbate sarcopenia, but the…”
    Get full text
    Journal Article
  6. 6

    Aberrant activation of ubiquitin D at G2 phase and apoptosis by carcinogens that evoke cell proliferation after 28-day administration in rats by Taniai, Eriko, Yafune, Atsunori, Hayashi, Hitomi, Itahashi, Megu, Hara-Kudo, Yukiko, Suzuki, Kazuhiko, Mitsumori, Kunitoshi, Shibutani, Makoto

    Published in Journal of toxicological sciences (2012)
    “…We have previously reported that renal carcinogens examined in rats increase tubular cell proliferation and topoisomerase (Topo) IIα+ cells. The present study…”
    Get full text
    Journal Article
  7. 7

    Relationship between CYP1A induction by indole-3-carbinol or flutamide and liver tumor-promoting potential in rats by Shimamoto, Keisuke, Dewa, Yasuaki, Kemmochi, Sayaka, Taniai, Eriko, Hayashi, Hitomi, Imaoka, Masako, Shibutani, Makoto, Mitsumori, Kunitoshi

    Published in Archives of toxicology (01-09-2011)
    “…To investigate liver tumor-promoting potentials of indole-3-carbinol (I3C) and flutamide (FLU), changes in mRNA expression of Cyp1a and genes encoding…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Induction of ovarian toxicity in a subchronic oral toxicity study of citrinin in female BALB/c mice by Hayashi, Hitomi, Itahashi, Megu, Taniai, Eriko, Yafune, Atsunori, Sugita-Konishi, Yoshiko, Mitsumori, Kunitoshi, Shibutani, Makoto

    Published in Journal of toxicological sciences (2012)
    “…The present study was performed to elucidate toxicity profile of citrinin (CTN) after repeated oral doses for 90 days, especially on the kidneys and female…”
    Get full text
    Journal Article
  11. 11

    Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model by Ichimura, Ryohei, Mizukami, Sayaka, Takahashi, Miwa, Taniai, Eriko, Kemmochi, Sayaka, Mitsumori, Kunitoshi, Shibutani, Makoto

    Published in Toxicology and applied pharmacology (01-08-2010)
    “…To clarify the involvement of signaling of transforming growth factor (TGF)-β during the hepatocarcinogenesis, the immunohistochemical distribution of related…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Threshold dose of liver tumor promoting effect of β-naphthoflavone in rats by Hayashi, Hitomi, Taniai, Eriko, Morita, Reiko, Yafune, Atsunori, Suzuki, Kazuhiko, Shibutani, Makoto, Mitsumori, Kunitoshi

    Published in Journal of toxicological sciences (2012)
    “…To determine the threshold dose of β-Naphthoflavone (BNF) that induces hepatocellular tumor promoting effects, reactive oxygen species (ROS) generation and…”
    Get full text
    Journal Article
  14. 14

    Hepatocellular adenoma with severe fatty change in a male Spontaneously Diabetic Torii rat by Taniai-Riya, Eriko, Miyajima, Katsuhiro, Kakimoto, Kochi, Ohta, Takeshi, Yasui, Yuzo, Kemmochi, Yusuke, Anagawa-Nakamura, Akiko, Toyoda, Kaoru, Takahashi, Akemi, Shoda, Toshiyuki

    Published in Journal of Toxicologic Pathology (2017)
    “…The Spontaneously Diabetic Torii (SDT) rat is a rat model of nonobese type 2 diabetes mellitus, and hepatocellular adenomas have not been reported in this…”
    Get full text
    Journal Article
  15. 15

    Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and β-naphthoflavone by Hayashi, Hitomi, Taniai, Eriko, Morita, Reiko, Hayashi, Masahiro, Nakamura, Daichi, Wakita, Atsushi, Suzuki, Kazuhiko, Shibutani, Makoto, Mitsumori, Kunitoshi

    Published in Journal of toxicological sciences (2012)
    “…Omeprazole (OPZ) and β-naphthoflavone (BNF) are cytochrome P450 (CYP)1A inducers and have liver tumor promoting effects. In this study, we investigated the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Hepatocarcinogenic Susceptibility of Fenofibrate and Its Possible Mechanism of Carcinogenicity in a Two-Stage Hepatocarcinogenesis Model of rasH2 Mice by Kawai, Masaomi, Jin, Meilan, Nishimura, Jihei, Dewa, Yasuaki, Saegusa, Yukie, Matsumoto, Sayaka, Taniai, Eriko, Shibutani, Makoto, Mitsumori, Kunitoshi

    Published in Toxicologic pathology (01-12-2008)
    “…Fenofibrate (FF) has previously been shown to induce hepatocellular neoplasia in a conventional mouse bioassay (NDA 1993), but there has been no report to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20